Canagold Resources Ltd.: Canagold Arranged and Closed $7.1 M Financing

Novo Nordisk's shares dropped 6% after it announced 2030 growth targets, including revenue growth in line with peers and plans to launch multiple blockbuster drugs. The company aims to expand its oral GLP-1 treatments and maintain an attractive dividend. Targets are based on a 2026 baseline and subject to uncertainty.

Oracle invested in 1.7 GW of wind energy projects in Texas, partnering with suppliers like Clearway Energy and Engie. The projects will supply power to ERCOT, supporting Oracle's goal of 100% carbon-free electricity for its AI data centers in Texas.

JD Sports appointed John Mersho as North America CEO to drive growth in the region, which contributed 38% of group sales. The company also signed a deal to open over 140 stores in Mexico and manage its e-commerce there starting 2027.

Oracle conducted a second mass layoff in 2026, notifying employees on September 14 with same-day termination. Affected staff lost system access before receiving emails. Severance terms include up to 26 weeks of pay, with unvested stock options canceled. The company has laid off 21,000 employees this fiscal year, raising restructuring costs by $700 million to $2.8 billion, partly due to AI adoption.

SK Hynix, Oreum Therapeutics, and Samsung Electro-Mechanics were top net buyers in Korea. Samsung Electronics rose 4.4% and SK Hynix gained 0.65%. Samsung Electronics offers a 4,604 won dividend per share. Oreum Therapeutics' stock fell after BMS halted development of a drug and terminated a $180M contract.

Kadant (KAI) announced leadership succession plans and a quarterly dividend of $0.36 per share. Its stock has fallen 15% in the past month to $265.56, with a 1-year return of -13%, though 3- and 5-year returns remain positive. Analysts debate its valuation, with some suggesting it's undervalued at $335 per share, while others note its high P/E ratio of 28.6x compared to peers.